Published ahead of print on June 29, 2006, doi:10.1164/rccm.200602-163OC
American Journal of Respiratory and Critical Care Medicine Vol 174. pp. 810-816, (2006)
© 2006 American Thoracic Society
doi: 10.1164/rccm.200602-163OC
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
Ganesh Raghu,
Derek Weycker,
John Edelsberg,
Williamson Z. Bradford and
Gerry Oster
University of Washington Medical Center, Seattle, Washington; Policy Analysis, Inc., Brookline, Massachusetts; and InterMune Pharmaceuticals, Brisbane, California
Correspondence and requests for reprints should be addressed to Ganesh Raghu, M.D., Division of Pulmonary and Critical Care Medicine, Interstitial Lung Disease, Sarcoid, and Pulmonary Fibrosis and Lung Transplant Programs, University of Washington, Seattle, WA 98195-6522. E-mail: graghu{at}u.washington.edu
Rationale: Idiopathic pulmonary fibrosis is a chronic interstitial lung disease of unknown etiology; its epidemiology in the United States has not been well characterized.
Objective: To estimate the annual incidence and prevalence of idiopathic pulmonary fibrosis in the United States.
Methods: Retrospective cohort design utilizing a large health care claims database spanning the period January 1996 through December 2000.
Measurements and Main Results: Persons with idiopathic pulmonary fibrosis were identified based on diagnosis and procedure codes. Using broad case-finding criteria, prevalence was estimated to range from 4.0 per 100,000 persons aged 18 to 34 yr to 227.2 per 100,000 among those 75 yr or older; annual incidence was estimated to range from 1.2 to 76.4 per 100,000. Using narrow case-finding criteria, prevalence ranged from 0.8 to 64.7 per 100,000 persons; comparable figures for incidence were 0.4 to 27.1 per 100,000 persons. Extrapolating these rates to the overall United States' population, prevalence was estimated to be 42.7 per 100,000 (incidence, 16.3 per 100,000) using broad criteria; with narrow criteria, prevalence was estimated to be 14.0 per 100,000 (incidence, 6.8 per 100,000).
Conclusions: Our results suggest that idiopathic pulmonary fibrosis is probably more common in the United States than previously reported.
Key Words: epidemiology lung diseases, interstitial retrospective studies
This article has been cited by other articles:

|
 |

|
 |
 
A. M. Tager, A. Sharma, and E. J. Mark
Case 32-2009 -- A 27-Year-Old Man with Progressive Dyspnea
N. Engl. J. Med.,
October 15, 2009;
361(16):
1585 - 1593.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Olson, J. J. Swigris, G. Raghu, and K. K. Brown
Seasonal Variation: Mortality From Pulmonary Fibrosis Is Greatest in the Winter
Chest,
July 1, 2009;
136(1):
16 - 22.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Kotsianidis, E. Nakou, I. Bouchliou, A. Tzouvelekis, E. Spanoudakis, P. Steiropoulos, I. Sotiriou, V. Aidinis, D. Margaritis, C. Tsatalas, et al.
Global Impairment of CD4+CD25+FOXP3+ Regulatory T Cells in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
June 15, 2009;
179(12):
1121 - 1130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Prasse, C. Probst, E. Bargagli, G. Zissel, G. B. Toews, K. R. Flaherty, M. Olschewski, P. Rottoli, and J. Muller-Quernheim
Serum CC-Chemokine Ligand 18 Concentration Predicts Outcome in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
April 15, 2009;
179(8):
717 - 723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Lynch III
Idiopathic Pulmonary Fibrosis, Nonspecific Interstitial Pneumonia/Fibrosis, and Sarcoidosis
ACCP Pulmonary Med Brd Rev,
January 1, 2009;
25(0):
635 - 686.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Hubbard, C. Smith, I. Le Jeune, J. Gribbin, and A. W. Fogarty
The Association between Idiopathic Pulmonary Fibrosis and Vascular Disease: A Population-based Study
Am. J. Respir. Crit. Care Med.,
December 15, 2008;
178(12):
1257 - 1261.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J Allan, J. Beattie, and D. J Flint
Epithelial injury induces an innate repair mechanism linked to cellular senescence and fibrosis involving IGF-binding protein-5
J. Endocrinol.,
November 1, 2008;
199(2):
155 - 164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Raghu, K. K. Brown, U. Costabel, V. Cottin, R. M. du Bois, J. A. Lasky, M. Thomeer, J. P. Utz, R. K. Khandker, L. McDermott, et al.
Treatment of Idiopathic Pulmonary Fibrosis with Etanercept: An Exploratory, Placebo-controlled Trial
Am. J. Respir. Crit. Care Med.,
November 1, 2008;
178(9):
948 - 955.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kim and K. C. Meyer
Review: Therapies for interstitial lung disease: past, present and future
Therapeutic Advances in Respiratory Disease,
October 1, 2008;
2(5):
319 - 338.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
V. J. Thannickal and J. E. Loyd
Idiopathic Pulmonary Fibrosis: A Disorder of Lung Regeneration?
Am. J. Respir. Crit. Care Med.,
October 1, 2008;
178(7):
663 - 665.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Cronkhite, C. Xing, G. Raghu, K. M. Chin, F. Torres, R. L. Rosenblatt, and C. K. Garcia
Telomere Shortening in Familial and Sporadic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
October 1, 2008;
178(7):
729 - 737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Vrielynck, T. Mamou-Mani, S. Emond, P. Scheinmann, F. Brunelle, and J. de Blic
Diagnostic Value of High-Resolution CT in the Evaluation of Chronic Infiltrative Lung Disease in Children
Am. J. Roentgenol.,
September 1, 2008;
191(3):
914 - 920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Han, S. Murray, C. D. Fell, K. R. Flaherty, G. B. Toews, J. Myers, T. V. Colby, W. D. Travis, E. A. Kazerooni, B. H. Gross, et al.
Sex differences in physiological progression of idiopathic pulmonary fibrosis
Eur. Respir. J.,
June 1, 2008;
31(6):
1183 - 1188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. U. Wells and C. M. Hogaboam
Update in Diffuse Parenchymal Lung Disease 2007
Am. J. Respir. Crit. Care Med.,
March 15, 2008;
177(6):
580 - 584.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. G. Luzina, N. W. Todd, A. T. Iacono, and S. P. Atamas
Roles of T lymphocytes in pulmonary fibrosis
J. Leukoc. Biol.,
February 1, 2008;
83(2):
237 - 244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Garcia, W. E. Wright, and J. W. Shay
Human diseases of telomerase dysfunction: insights into tissue aging
Nucleic Acids Res.,
December 3, 2007;
35(22):
7406 - 7416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tzouvelekis, V. Harokopos, T. Paparountas, N. Oikonomou, A. Chatziioannou, G. Vilaras, E. Tsiambas, A. Karameris, D. Bouros, and V. Aidinis
Comparative Expression Profiling in Pulmonary Fibrosis Suggests a Role of Hypoxia-inducible Factor-1{alpha} in Disease Pathogenesis
Am. J. Respir. Crit. Care Med.,
December 1, 2007;
176(11):
1108 - 1119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Patel, D. J. Lederer, A. C. Borczuk, and S. M. Kawut
Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis
Chest,
September 1, 2007;
132(3):
998 - 1006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Noth and F. J. Martinez
Recent Advances in Idiopathic Pulmonary Fibrosis
Chest,
August 1, 2007;
132(2):
637 - 650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Olson, J. J. Swigris, D. C. Lezotte, J. M. Norris, C. G. Wilson, and K. K. Brown
Mortality from Pulmonary Fibrosis Increased in the United States from 1992 to 2003
Am. J. Respir. Crit. Care Med.,
August 1, 2007;
176(3):
277 - 284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Pierce, K. Carpenter, C. Jakubzick, S. L. Kunkel, H. Evanoff, K. R. Flaherty, F. J. Martinez, G. B. Toews, and C. M. Hogaboam
Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21
Eur. Respir. J.,
June 1, 2007;
29(6):
1082 - 1093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Richeldi and E. Abraham
Identifying Patients with Idiopathic Pulmonary Fibrosis: Quality or Quantity?
Am. J. Respir. Crit. Care Med.,
May 15, 2007;
175(10):
976 - 977.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Alakhras, P. A. Decker, H. F. Nadrous, M. Collazo-Clavell, and J. H. Ryu
Body Mass Index and Mortality in Patients With Idiopathic Pulmonary Fibrosis
Chest,
May 1, 2007;
131(5):
1448 - 1453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. D. Tsakiri, J. T. Cronkhite, P. J. Kuan, C. Xing, G. Raghu, J. C. Weissler, R. L. Rosenblatt, J. W. Shay, and C. K. Garcia
Adult-onset pulmonary fibrosis caused by mutations in telomerase
PNAS,
May 1, 2007;
104(18):
7552 - 7557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. U. Wells and C. M. Hogaboam
Update in Diffuse Parenchymal Lung Disease 2006
Am. J. Respir. Crit. Care Med.,
April 1, 2007;
175(7):
655 - 660.
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 American Thoracic Society
|
|
|